kol call friday may et discuss oral cgrp launch
host confer call friday et discuss on-going launch
oral cgrp acut migrain call featur kol treat
migrain patient year extens experi oral cgrp
recal biohaven receiv fda approv nurtec end februari note
launch product mid-march pandem
allergan raymond launch first oral cgrp ubrelvi mid-
januari pre-pandem plan compar two drug profil discuss
respect launch especi context on-going triptan use lilli reyvow launch
on-going pandem pleas contact piper sandler salesperson
date/tim friday et pt
kol board-certifi neurologist special headach medicin
year graduat medic degre keck school medicin
univers southern california subsequ complet resid
fellowship neurolog clinic neurophysiolog harbor-ucla medic center
publish sever articl peer-review journal written book chapter
headach biolog migrain treatment paradigm also frequent lectur
headach disord across world consult pharmaceut
industri research develop medic treat headach
brief overview topic highlight pleas contact
tyler van buren addit question
launch oral cgrp nurtec biohaven ubrelvi allergan/abb
use rel triptan lilli reyvow lasmitidan
aim understand earli physician patient experi oral
cgrp term efficaci safeti coverage/reimburs
kol highlight prescrib challeng neurologist face light
pandem challeng affect respect launch
oral cgrp
final short discuss nurtec migrain prevent data
current use inject cgrp prevent aimovig vyepti emgal ajovi
clinic risk rimegep treatment acut migrain
biohaven develop cgrp antagonist glutam drug mpo inhibitor
dcf base rimegep
migrain sale us valu
inhal migrain sever phase
troriluzol program
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
acut treatment migrain
prevent migrain
acut treatment migrain
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
page
good sold
revenu
revenu
revenu
revenu
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
page
good sold
revenu
revenu
revenu
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
